{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:27:51Z","timestamp":1793755671738,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.rmed.2020.106290","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T19:13:02Z","timestamp":1610565182000},"page":"106290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis"],"prefix":"10.1016","volume":"178","author":[{"given":"Elizabeth Stucky","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayu","family":"Wilopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2020.106290_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1744-313X.2011.01078.x","article-title":"Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis","volume":"39","author":"Harrison","year":"2012","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.rmed.2020.106290_bib2","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2015.10.114","article-title":"Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis","volume":"33","author":"Kosmidis","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.rmed.2020.106290_bib3","article-title":"Innate and adaptive immune defects in chronic pulmonary aspergillosis","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.rmed.2020.106290_bib4","unstructured":"Doffinger, R.; Harris, C.; Lear, S.; Newton, P.; Alachkar, H.; Kumararatne, D.S.; Denning, D.W. Reduced gamma interferon (gIFN) production in chronic pulmonary aspergillosis (CPA). In Proceedings of 5th Advances against Aspergillus Conference, Istanbul, Turkey."},{"key":"10.1016\/j.rmed.2020.106290_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/506477","article-title":"Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia","volume":"194","author":"Seppanen","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.rmed.2020.106290_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.106290_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mmy\/myv020","article-title":"Antibody testing in aspergillosis--quo vadis?","volume":"53","author":"Page","year":"2015","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rmed.2020.106290_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","article-title":"Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)","volume":"72","author":"Page","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.rmed.2020.106290_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00538-19","article-title":"Evaluation of LDBio Aspergillus ICT lateral flow assay for IgG and IgM antibody detection in chronic pulmonary aspergillosis","volume":"57","author":"Stucky Hunter","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.rmed.2020.106290_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0091-6749(86)90108-9","article-title":"Antigens and allergens of Aspergillus fumigatus. I. Characterization by quantitative immunoelectrophoretic techniques","volume":"78","author":"Longbottom","year":"1986","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2020.106290_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mimet.2017.06.016","article-title":"Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA","volume":"140","author":"Fayemiwo","year":"2017","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.rmed.2020.106290_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12890-016-0276-3","article-title":"Aspergillus nodules; another presentation of Chronic Pulmonary Aspergillosis","volume":"16","author":"Muldoon","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2020.106290_bib13","unstructured":"Wilopo, B.; Hunter, E.; Page, I.; Moore, C.; Richardson, M.D.; Denning, D.W. Aspergillus-specific IgG assay optimum cut-off for the diagnosis of chronic pulmonary aspergillosis. In Proceedings of 9th Trends in Medical Mycology, Nice, France."},{"key":"10.1016\/j.rmed.2020.106290_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/mmy\/myaa026","article-title":"Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis","volume":"58","author":"Bongomin","year":"2020","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rmed.2020.106290_bib15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fmicb.2019.01438","article-title":"Role of the aspergillus-specific IgG and IgM test in the diagnosis and follow-up of chronic pulmonary aspergillosis","volume":"10","author":"Li","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rmed.2020.106290_bib16","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1111\/1469-0691.12133","article-title":"Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis","volume":"19","author":"Baxter","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.rmed.2020.106290_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12281-018-0321-1","article-title":"Role of serological tests in the diagnosis of mold infections","volume":"12","author":"Richardson","year":"2018","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.rmed.2020.106290_bib18","doi-asserted-by":"crossref","first-page":"e9436","DOI":"10.1097\/MD.0000000000009436","article-title":"Evaluation of a commercial quantitative Aspergillus fumigatus-specific IgM assay for the diagnosis of invasive pulmonary aspergillosis","volume":"96","author":"Yao","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.rmed.2020.106290_bib19","article-title":"Evaluation of the LDBio Aspergillus ICT lateral flow assay for serodiagnosis of allergic bronchopulmonary aspergillosis","volume":"15","author":"Stucky Hunter","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2020.106290_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thoraxjnl-2019-213606","article-title":"Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all-cause hospital admission","volume":"75","author":"Monk","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2020.106290_bib21","doi-asserted-by":"crossref","first-page":"106021","DOI":"10.1016\/j.mimet.2020.106021","article-title":"Optimising the cut-off of the Bordier Aspergillus IgG ELISA for the diagnosis of chronic pulmonary aspergillosis","volume":"176","author":"Wilopo","year":"2020","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.rmed.2020.106290_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/myc.12815","article-title":"Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis","volume":"61","author":"Sehgal","year":"2018","journal-title":"Mycoses"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120304303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120304303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:14:41Z","timestamp":1760616881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120304303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":22,"alternative-id":["S0954611120304303"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106290","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106290"}}